08/04/2026
Patrick Soon Shiong, a physician scientist and entrepreneur, is working on a drug called Anktiva. This treatment is designed to activate natural killer cells, a key part of the immune system that helps the body identify and destroy harmful cells, including cancer cells. Instead of relying only on chemotherapy or radiation, this approach focuses on strengthening the body’s own defenses.
For patients, this idea represents a shift toward immunotherapy, where the goal is to help the immune system do more of the work. While research and clinical evaluation are still ongoing, treatments like this are part of a broader movement in cancer care aimed at improving outcomes and reducing side effects.
This kind of progress matters because it focuses on both survival and quality of life. If therapies like Anktiva continue to show positive results, they could help shape a future where cancer treatment becomes more personalized and less physically demanding for millions of people worldwide.